Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: The primary objective of the study is to demonstrate the efficacy of low-dose IFN-β in reducing the risk of SARS-CoV-2 recently infected elderly patients to progress towards severe COVID-19 versus 1. To assess the reduction in Intensive Care Unit (ICU) admission in patients treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Aricò, Eleonora, Castiello, Luciano, Bracci, Laura, Urbani, Francesca, Lombardo, Flavia, Bacigalupo, Ilaria, Ancidoni, Antonio, Vanacore, Nicola, Falcione, Alessandro, Reggiani, Chiara, Dutti, Giovanni Marco, Maglie, Maria Grazia, Papa, Ombretta, Bartoletti, Pier Luigi, Ozzella, Giuseppina, Bevilacqua, Nazario, Nicastri, Emanuele, Belardelli, Filippo, Sconocchia, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413691/
https://www.ncbi.nlm.nih.gov/pubmed/34479601
http://dx.doi.org/10.1186/s13063-021-05367-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413691/
https://www.ncbi.nlm.nih.gov/pubmed/34479601
http://dx.doi.org/10.1186/s13063-021-05367-6

Ejemplares similares